1. Cell Cycle/DNA Damage Cytoskeleton Apoptosis Epigenetics
  2. MASTL Apoptosis Aurora Kinase PARP Caspase
  3. MKI-3

MKI-3 是一种选择性微管相关丝氨酸/苏氨酸激酶样 (MASTL) 抑制剂,IC50 为 5.72 nM,Kd 为 1.89 nM。MKI-3 可并破坏 MASTL-ENSA-Aurora A 信号轴。MKI-3 可诱导癌细胞出现染色体不稳定性、有丝分裂灾难和细胞凋亡 (apoptosis)。MKI-3 可用于三阴性乳腺癌的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

MKI-3

MKI-3 Chemical Structure

CAS No. : 3084702-28-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

MKI-3 is a selective microtubule-associated serine/threonine kinase-like (MASTL) inhibitor with an IC50 of 5.72 nM and a Kd of 1.89 nM. MKI-3 disrupts the MASTL-ENSA-Aurora A signaling axis. MKI-3 induces chromosomal instability, mitotic catastrophe and apoptosis (apoptosis) in cancer cells. MKI-3 is applicable to research related to triple-negative breast cancer[1].

体外研究
(In Vitro)

MKI-3 可抑制细胞内 MASTL 活性,其 IC50 值为 114.9 nM[1]
MKI-3 (72 h) 可抑制乳腺癌细胞系 4T1、MCF7、MDA-MB-231 和 BT549 的增殖,其 IC50 值分别为 42.01 nM、93.61 nM、91.44 nM 和 160.9 nM[1]
MKI-3 (250 nM; 12 h) 可抑制 MASTL-ENSA-Aurora A 信号轴,在 BT549 和 4T1 乳腺癌细胞中诱导凋亡标志物[1]
MKI-3 (250 nM; 24 h) 可激活 BT549 乳腺癌细胞中的 PP2A[1]
MKI-3 (250 nM; 24 h) 可在 BT549 乳腺癌细胞中诱导有丝分裂缺陷,包括异常核形态、多极纺锤体和中心体异常[1]
MKI-3 (250 nM; 48 h) 对 BT549 乳腺癌细胞的抗增殖活性部分由 PP2A 的激活介导,因为与 20 nM okadaic acid 共同处理可恢复细胞活力[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: BT549 and 4T1 breast cancer cells
Concentration: 250 nM
Incubation Time: 12 h
Result: Reduced levels of phosphorylated ENSA (pENSA) and phosphorylated Aurora A (p-Aurora A), and increased levels of cleaved poly(ADP-ribose) polymerase (PARP) and gamma H2A histone family member X (γ-H2AX), markers of mitotic apoptosis.
体内研究
(In Vivo)

MKI-3 (8 mg/kg;腹腔注射;每日;2 周) 可显著抑制 4T1 三阴性乳腺癌小鼠模型中的肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 4T1 syngeneic mouse model[1]
Dosage: 8 mg/kg
Administration: i.p.; daily; 2 weeks
Result: Reduced mean nuclear size diameter.
Increased cells staining positive for phospho-histone H3 and cleaved caspase-3.
Significantly reduced phosphorylation of ENSA and Aurora A in tumor tissues, with near-complete suppression relative to controls.
分子量

385.42

Formula

C21H19N7O

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
MKI-3
目录号:
HY-182391
需求量: